文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

Omicron B.1.1.529 subvariant: Brief evidence and future prospects.

作者信息

Farahat Ramadan Abdelmoez, Baklola Mohamed, Umar Tungki Pratama

机构信息

Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.

Faculty of Medicine, Mansoura University, Mansoura, Egypt.

出版信息

Ann Med Surg (Lond). 2022 Nov;83:104808. doi: 10.1016/j.amsu.2022.104808. Epub 2022 Oct 31.

DOI:10.1016/j.amsu.2022.104808

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9621621/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aab/9640306/36f2f712deef/gr1.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aab/9640306/36f2f712deef/gr1.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aab/9640306/36f2f712deef/gr1.jpg

相似文献

[1]

Omicron B.1.1.529 subvariant: Brief evidence and future prospects.

Ann Med Surg (Lond). 2022-11

[2]

Case Report: Omicron BA.2 Subvariant of SARS-CoV-2 Outcompetes BA.1 in Two Co-infection Cases.

Front Genet. 2022-4-12

[3]

The First Outbreak of Omicron Subvariant BA.5.2 - Beijing Municipality, China, July 4, 2022.

China CDC Wkly. 2022-7-29

[4]

Vitamin D levels and clinical outcomes of SARS-CoV-2 Omicron subvariant BA.2 in children: A longitudinal cohort study.

Front Nutr. 2022-7-25

[5]

First Imported Case of SARS-CoV-2 Omicron Subvariant BA.5 - Shanghai Municipality, China, May 13, 2022.

China CDC Wkly. 2022-7-29

[6]

Novel Method for Rapid Detection of COVID-19 Omicron Variant and Future Emerging Variants.

Discov Med. 2022

[7]

Emergence of a SARS-CoV-2 Omicron Subvariant BA.2.2 with a 454-Nucleotide Genomic Deletion - Sichuan Province, China, May 10, 2022.

China CDC Wkly. 2022-10-7

[8]

First Imported Case of SARS-CoV-2 Omicron Subvariant BA.2.12.1 - Guangdong Province, China, April 30, 2022.

China CDC Wkly. 2022-8-5

[9]

Omicron BA.2.75 Subvariant of SARS-CoV-2 Is Expected to Have the Greatest Infectivity Compared with the Competing BA.2 and BA.5, Due to Most Negative Gibbs Energy of Binding.

BioTech (Basel). 2022-10-11

[10]

Detection of the XE subvariant of SARS-CoV-2: A perspective.

Int J Surg. 2022-5

引用本文的文献

[1]

Genetic Diversity and Spatiotemporal Distribution of SARS-CoV-2 Variants in Guinea: A Meta-Analysis of Sequence Data (2020-2023).

Viruses. 2025-1-31

[2]

Preparedness of South Asian countries regarding Langya virus emergence: A view on the current situation.

Health Care Sci. 2023-4-18

[3]

The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China.

Front Immunol. 2024

[4]

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study.

Front Immunol. 2023

[5]

The evolution of SARS-CoV-2 and the COVID-19 pandemic.

PeerJ. 2023

[6]

The polymorphisms of TNF-α related-gene and antibody production following third dose of COVID-19 vaccination: A pilot study.

Vacunas. 2023-4-10

[7]

Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies.

Int J Surg Open. 2023-6

[8]

Healthcare system preparedness for the next pandemic beyond COVID-19 situation.

J Prev Med Hyg. 2022-12-31

[9]

Efficacy of Tocilizumab in Management of COVID-19 Patients Admitted to Intensive Care Units: A Multicenter Retrospective Cohort Study.

Medicina (Kaunas). 2022-12-27

本文引用的文献

[1]

Evidence of co-infections during Delta and Omicron SARS-CoV-2 variants co-circulation through prospective screening and sequencing.

Clin Microbiol Infect. 2022-11

[2]

Immune boosting by B.1.1.529 Omicron) depends on previous SARS-CoV-2 exposure.

Science. 2022-7-15

[3]

Genetic differentiation and diversity of SARS-CoV-2 Omicron variant in its early outbreak.

Biosaf Health. 2022-6

[4]

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.

Science. 2022-5-6

[5]

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.

N Engl J Med. 2022-4-21

[6]

Omicron (B.1.1.529) variant of SARS-CoV-2: Concerns, challenges, and recent updates.

J Med Virol. 2022-6

[7]

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.

Nature. 2022-3

[8]

Covid-19: Omicron drives weekly record high in global infections.

BMJ. 2022-1-11

[9]

Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.

Eur Rev Med Pharmacol Sci. 2021-12

[10]

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.

Biochem Biophys Res Commun. 2022-1-29

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索